NYSE:ALT - Altimmune News Headlines

Sign in or create an account to add this stock to your watchlist.
$2.99 0.00 (0.00 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$2.99
Today's Range$2.87 - $3.0090
52-Week Range$1.70 - $58.50
Volume164,328 shs
Average Volume557,856 shs
Market Capitalization$26.18 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Altimmune (NYSE ALT) News Headlines

Source:
DateHeadline
Altimmune up 5% premarket ahead of HepTCell presentationAltimmune up 5% premarket ahead of HepTCell presentation
seekingalpha.com - January 29 at 11:37 AM
Altimmune Inc.Altimmune Inc.
www.barrons.com - January 16 at 3:39 PM
Altimmune Reports Mixed Bag Of UpdatesAltimmune Reports Mixed Bag Of Updates
seekingalpha.com - December 17 at 3:29 PM
BRIEF-Altimmune Announces Clinical Program Updates And Plans For Pipeline ExpansionBRIEF-Altimmune Announces Clinical Program Updates And Plans For Pipeline Expansion
www.msn.com - December 13 at 10:53 AM
Altimmune slips 5% premarket on disappointing NasoShield dataAltimmune slips 5% premarket on disappointing NasoShield data
seekingalpha.com - December 13 at 10:53 AM
Gaithersburg biotech names new CEOGaithersburg biotech names new CEO
www.bizjournals.com - December 4 at 3:28 PM
Altimmune Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Altimmune Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - December 1 at 10:06 AM
Global Human Vaccines IndustryGlobal Human Vaccines Industry
www.marketwatch.com - November 15 at 3:24 PM
Altimmune up 7% premarket after Q3 updateAltimmune up 7% premarket after Q3 update
seekingalpha.com - November 14 at 9:28 AM
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate UpdateAltimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 14 at 9:28 AM
Will Altimmune (ALT) Report Negative Earnings Next Week? What You Should KnowWill Altimmune (ALT) Report Negative Earnings Next Week? What You Should Know
www.zacks.com - November 2 at 9:18 AM
Altimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - SlideshowAltimmune (ALT) Presents At DAWSON JAMES 4th Annual Small Cap Growth Conference - Slideshow
seekingalpha.com - November 1 at 8:58 AM
Altimmune to Present at Dawson James Securities 4th Annual Small Cap Growth ConferenceAltimmune to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
finance.yahoo.com - October 26 at 3:24 PM
Gaithersburg biotech CEO to step downGaithersburg biotech CEO to step down
finance.yahoo.com - October 23 at 3:22 PM
Today’s Research Reports on Stocks to Watch: Altimmune and MannKindToday’s Research Reports on Stocks to Watch: Altimmune and MannKind
finance.yahoo.com - October 17 at 8:45 AM
Altimmune Declines Too MuchAltimmune Declines Too Much
seekingalpha.com - October 10 at 8:36 AM
Pre-Open Movers 10/08: (PBR) (TTPH) (ARNC) Higher; (ALT) (GLUU) (IRBT) Lower (more...)Pre-Open Movers 10/08: (PBR) (TTPH) (ARNC) Higher; (ALT) (GLUU) (IRBT) Lower (more...)
www.streetinsider.com - October 8 at 3:20 PM
Altimmune announces $25M registered direct offering; shares down 31% premarketAltimmune announces $25M registered direct offering; shares down 31% premarket
seekingalpha.com - October 8 at 3:20 PM
Why Altimmune Stock Is Sliding Lower TodayWhy Altimmune Stock Is Sliding Lower Today
investorplace.com - October 8 at 1:00 PM
Altimmunes flu vaccine nasal spray shows strong immune effect in mid-stage study; shares up 38%Altimmune's flu vaccine nasal spray shows strong immune effect in mid-stage study; shares up 38%
seekingalpha.com - October 6 at 8:31 AM
Altimmune Closes on $16.9 Million in FundingAltimmune Closes on $16.9 Million in Funding
finance.yahoo.com - October 3 at 8:18 AM
Form 8-K Altimmune, Inc. For: Sep 28Form 8-K Altimmune, Inc. For: Sep 28
www.streetinsider.com - October 2 at 8:34 AM
Today’s Research Reports on Stocks to Watch: Aytu Bioscience and AltimmuneToday’s Research Reports on Stocks to Watch: Aytu Bioscience and Altimmune
finance.yahoo.com - October 1 at 8:18 AM
Altimmune (ALT) Prices $12 Million Underwritten Public Offering of Common Units and Pre-funded UnitsAltimmune (ALT) Prices $12 Million Underwritten Public Offering of Common Units and Pre-funded Units
www.streetinsider.com - September 28 at 3:21 PM
Altimmune prices equity offering at $5/unit; shares down 49% premarketAltimmune prices equity offering at $5/unit; shares down 49% premarket
seekingalpha.com - September 28 at 3:21 PM
Altimmune readies equity offering; shares down 4% after hoursAltimmune readies equity offering; shares down 4% after hours
seekingalpha.com - September 27 at 8:21 AM
Altimmune Awarded $2.5 Million in Additional BARDA Funding to Support NasoShield™ DevelopmentAltimmune Awarded $2.5 Million in Additional BARDA Funding to Support NasoShield™ Development
finance.yahoo.com - September 24 at 8:12 AM
MTEM Abuzz, TLRY Up 1,240% In 2 Months, ALT Awaits Anthrax Data In Q4MTEM Abuzz, TLRY Up 1,240% In 2 Months, ALT Awaits Anthrax Data In Q4
www.nasdaq.com - September 20 at 7:55 AM
Why Altimmune Stock Is Skyrocketing TodayWhy Altimmune Stock Is Skyrocketing Today
investorplace.com - September 19 at 5:45 PM
Altimmune jumps 99%Altimmune jumps 99%
seekingalpha.com - September 19 at 3:22 PM
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza VaccineAltimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine
globenewswire.com - September 4 at 3:20 PM
Altimmune -9.1% on offering of 58M unitsAltimmune -9.1% on offering of 58M units
seekingalpha.com - August 18 at 6:57 AM
Altimmune, Inc (ALT) CEO Bill Enright on Q2 2018 Results - Earnings Call TranscriptAltimmune, Inc (ALT) CEO Bill Enright on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 15 at 3:18 PM
Altimmune Announces Second Quarter 2018 Financial Results and Provides Corporate UpdateAltimmune Announces Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 15 at 7:15 AM
Altimmune, Inc. to Host Earnings CallAltimmune, Inc. to Host Earnings Call
finance.yahoo.com - August 15 at 7:15 AM
Altimmune -16% on securities offeringAltimmune -16% on securities offering
seekingalpha.com - July 31 at 6:37 AM
Free Technical Research Reports on Biotech Stocks -- Alkermes, Alnylam Pharma, Altimmune, and Alexion PharmaFree Technical Research Reports on Biotech Stocks -- Alkermes, Alnylam Pharma, Altimmune, and Alexion Pharma
www.marketwatch.com - July 24 at 8:37 AM
Altimmune (ALT) Enters Pact with Majority of Remaining Series B Investors to Restructure AgreementsAltimmune (ALT) Enters Pact with Majority of Remaining Series B Investors to Restructure Agreements
www.streetinsider.com - July 12 at 3:17 PM
Altimmune (ALT) Appoints Mitchel Sayare as Executive ChairmanAltimmune (ALT) Appoints Mitchel Sayare as Executive Chairman
www.streetinsider.com - July 10 at 3:17 PM
Altimmune (ALT) Restructures Financing AgreementAltimmune (ALT) Restructures Financing Agreement
www.streetinsider.com - June 23 at 5:30 AM
Altimmune Restructures Financing AgreementAltimmune Restructures Financing Agreement
finance.yahoo.com - June 23 at 5:30 AM
Short Interest Trends Higher in Solar, Lower in Alt Energy StocksShort Interest Trends Higher in Solar, Lower in Alt Energy Stocks
finance.yahoo.com - January 11 at 8:31 AM
Maryland substitute teacher fired after alt-right views discovered by studentsMaryland substitute teacher fired after 'alt-right' views discovered by students
www.foxnews.com - January 6 at 6:13 PM
Can The X-Files Reclaim Alien Conspiracies From The Alt-Right?Can 'The X-Files' Reclaim Alien Conspiracies From The Alt-Right?
www.forbes.com - January 5 at 6:05 PM
Jon Bernthal has blunt response to alt-right fans of The PunisherJon Bernthal has blunt response to alt-right fans of 'The Punisher'
www.foxnews.com - January 5 at 6:05 PM
Should You Be Concerned About Altimmune Inc’s (NASDAQ:ALT) Investors?Should You Be Concerned About Altimmune Inc’s (NASDAQ:ALT) Investors?
finance.yahoo.com - January 5 at 6:05 PM
Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of DirectorsAltimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors
finance.yahoo.com - January 3 at 8:57 AM
Colorado Shooter Matthew Riehl Shared Alt-Right MemesColorado Shooter Matthew Riehl Shared Alt-Right Memes
www.msn.com - January 2 at 8:21 AM
Kenji Lopez-Alt, the Man Who Conquered Pie Crust With ScienceKenji Lopez-Alt, the Man Who Conquered Pie Crust With Science
www.msn.com - January 1 at 6:17 PM
Alt-Right Street Artist Sabo Calls GOP The New Punks; Hes WrongAlt-Right Street Artist 'Sabo' Calls GOP The New Punks; He's Wrong
www.forbes.com - December 29 at 6:13 PM
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel